Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-14

FDA Approved: ICATIBANT — Original Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Alembic Pharmaceuticals Limited's generic icatibant (ANDA213773) for the treatment of acute attacks of hereditary angioedema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ICATIBANT (icatibant)

Snippet

ORIG AP for ICATIBANT (ICATIBANT)